Page 8 of 32 · 749 questions tagged coa.
What I have: a GLP-1 receptor agonist · six weeks · 30 °C. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is…
Stated plainly: 99.1% · sampling plan. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the…
Details up front: JEEP · dulaglutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists…
What I am working with: ERP · identity confirmation by mass spectrometry. I have worked this out and I would like someone to find the error, because I suspect there…
A vendor sent me a report showing a clean deconvolved mass at 4113.6 for semaglutide with, in their words, "no impurity peaks detected". Their sales copy turns that…
Details up front: batch certificate · WXT. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
Costs, fees and monitoring all included, I am trying to compare like with like. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware…
The case in front of me: semaglutide · twelve weeks · room temperature. I want to decide this in advance so that I am not deciding it under pressure later. Assume I…
What I am working with: BCH · GL Biochem (Shanghai). Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
The particulars: 99.1% · PeptideMeter · 96.8%. An unexpected observation, and I would like a differential rather than reassurance. The conditions were within what I…
Setup, so nobody has to ask: lot-specific certificate · JEEP. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
Stated plainly: an endotoxin test · a ten-person group buy. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
Concretely: ecnoglutide · four weeks · 30 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
I am comparing three suppliers on documentation rather than on price. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have…
The particulars: 96.4% · list of related substances. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
Stated plainly: QSC · peptide mapping. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…
Details up front: 95.2% · lot-specific certificate. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear…
Setup, so nobody has to ask: 98.2% · a C18 column · ecnoglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the…
The case in front of me: 95.2% · VendorInvestigate · 97.9%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without…
The case in front of me: Homopeptide · Wuhan Wansheng Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first…
Stated plainly: Medutest · Xi’an Mokemei Biotechnology. I have read the primary source rather than the summary, which has left me with more questions. I understand…
The particulars: peptide mapping · ecnoglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each and…
The case in front of me: 99.1% · a C4 column · retatrutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
Details up front: an HPLC purity test · retatrutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…